We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-11.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$10.6B
AUM Growth
-$1.52B
Cap. Flow
+$47.1M
Cap. Flow %
0.44%
Top 10 Hldgs %
18.51%
Holding
395
New
8
Increased
194
Reduced
112
Closed
28

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$66.2M
2
MTB icon
M&T Bank
MTB
+$43.8M
3
BKR icon
Baker Hughes
BKR
+$38.3M
4
ORCL icon
Oracle
ORCL
+$36.5M
5
CDK
CDK Global, Inc.
CDK
+$35.6M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 17.05%
3 Financials 15.67%
4 Industrials 13.84%
5 Consumer Discretionary 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
76
McDonald's
MCD
$194B
$47M 0.44%
190,211
-1,643
-0.9% -$405K
MRSH
77
Marsh
MRSH
$91.7B
$46.7M 0.44%
300,554
-29,564
-9% -$4.74M
ADI icon
78
Analog Devices
ADI
$178B
$46.5M 0.44%
318,064
+81,397
+34% +$12.8M
PNC icon
79
PNC Financial Services
PNC
$100B
$45.1M 0.43%
286,057
-2,739
-0.9% -$459K
MTD icon
80
Mettler-Toledo International
MTD
$28.1B
$45.1M 0.43%
39,264
-404
-1% -$508K
RPM icon
81
RPM International
RPM
$14.3B
$44.4M 0.42%
563,614
+9,192
+2% +$772K
EXPD icon
82
Expeditors International
EXPD
$22.4B
$43.9M 0.41%
449,958
+5,606
+1% +$574K
QLYS icon
83
Qualys
QLYS
$4.78B
$43.3M 0.41%
343,204
-47,861
-12% -$6.27M
ITW icon
84
Illinois Tool Works
ITW
$84.9B
$42.7M 0.4%
234,259
-2,552
-1% -$511K
CSGS
85
DELISTED
CSG Systems International
CSGS
$42.4M 0.4%
710,805
+6,187
+0.9% +$375K
HSIC icon
86
Henry Schein
HSIC
$9.76B
$42.1M 0.4%
548,145
+5,149
+0.9% +$432K
TXRH icon
87
Texas Roadhouse
TXRH
$13.5B
$42M 0.4%
573,601
+5,673
+1% +$446K
TEL icon
88
TE Connectivity
TEL
$62.1B
$41.2M 0.39%
363,952
+4,696
+1% +$582K
SCI icon
89
Service Corp International
SCI
$11.7B
$41.1M 0.39%
594,320
-2,890
-0.5% -$198K
SIGI icon
90
Selective Insurance
SIGI
$5.63B
$40.8M 0.39%
469,659
+3,922
+0.8% +$319K
BR icon
91
Broadridge
BR
$18.3B
$40.6M 0.38%
284,793
+50,781
+22% +$7.37M
CBOE icon
92
Cboe Global Markets
CBOE
$31.1B
$40.5M 0.38%
358,098
+60,617
+20% +$6.81M
SJM icon
93
J.M. Smucker
SJM
$13.2B
$40.2M 0.38%
313,972
+42,559
+16% +$5.68M
RVTY icon
94
Revvity
RVTY
$12.4B
$40.1M 0.38%
282,260
+5,922
+2% +$887K
HAE icon
95
Haemonetics
HAE
$3.75B
$39.6M 0.37%
607,976
-222,914
-27% -$13.2M
CLB icon
96
Core Laboratories
CLB
$493M
$39.5M 0.37%
+1,993,528
New +$53M
NDSN icon
97
Nordson
NDSN
$16.9B
$38.7M 0.37%
191,128
+33,877
+22% +$7.23M
SLGN icon
98
Silgan Holdings
SLGN
$5.07B
$38.6M 0.36%
933,969
+7,406
+0.8% +$326K
DOX icon
99
Amdocs
DOX
$5.83B
$38.4M 0.36%
461,409
+4,351
+1% +$359K
ICUI icon
100
ICU Medical
ICUI
$4.14B
$38M 0.36%
231,199
+781
+0.3% +$150K

Similar funds

Boston Trust Walden's Q2 2022 Portfolio in Review

As of Q2 2022, Boston Trust Walden held 395 positions worth $10.6B, down 13% from $12.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Boston Trust Walden's Q2 2022 filing shows 8 new, 194 increased, 112 reduced and 28 closed positions. Its largest new stake was Core Laboratories: 1,993,528 shares worth $39.5M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $66.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q2 2022 buy was Core Laboratories: 1,993,528 shares worth $39.5M.
  • Boston Trust Walden added most to Americold in Q2 2022, an estimated $32.5M increase.
  • Boston Trust Walden's biggest Q2 2022 reduction was M&T Bank, cutting an estimated $43.8M.
  • Boston Trust Walden fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $66.2M.
  • Boston Trust Walden's ten largest holdings make up 19% of its $10.6B portfolio in Q2 2022.
  • Boston Trust Walden opened 8 new positions and closed 28 in Q2 2022.
  • Boston Trust Walden's portfolio value fell 13% quarter-over-quarter to $10.6B.

Based on Boston Trust Walden's 13F filing for Q2 2022, filed 22 Jul 2022.